摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(3-benzyloxy-phenyl)-2,4-dioxo-butyric acid ethyl ester | 57696-13-6

中文名称
——
中文别名
——
英文名称
4-(3-benzyloxy-phenyl)-2,4-dioxo-butyric acid ethyl ester
英文别名
Ethyl-(m-benzyloxyphenyl)-pyruvate;Ethyl 2,4-dioxo-4-(3-phenylmethoxyphenyl)butanoate
4-(3-benzyloxy-phenyl)-2,4-dioxo-butyric acid ethyl ester化学式
CAS
57696-13-6
化学式
C19H18O5
mdl
——
分子量
326.349
InChiKey
NOADONVIZUCJNO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    24
  • 可旋转键数:
    9
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    69.7
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Discovery of α,γ-Diketo Acids as Potent Selective and Reversible Inhibitors of Hepatitis C Virus NS5b RNA-Dependent RNA Polymerase
    摘要:
    alpha,gamma-Diketo acids (DKA) were discovered from screening as selective and reversible inhibitors of hepatitis C virus NS5b RNA-dependent RNA polymerase. The diketo acid moiety proved essential for activity, while substitution on the gamma position was necessary for selectivity and potency. Optimization led to the identification of a DKA inhibitor of NS5b polymerase with IC50 = 45 nM, one of the most potent HCV NS5b polymerase inhibitors reported.
    DOI:
    10.1021/jm0342109
  • 作为产物:
    参考文献:
    名称:
    Discovery of α,γ-Diketo Acids as Potent Selective and Reversible Inhibitors of Hepatitis C Virus NS5b RNA-Dependent RNA Polymerase
    摘要:
    alpha,gamma-Diketo acids (DKA) were discovered from screening as selective and reversible inhibitors of hepatitis C virus NS5b RNA-dependent RNA polymerase. The diketo acid moiety proved essential for activity, while substitution on the gamma position was necessary for selectivity and potency. Optimization led to the identification of a DKA inhibitor of NS5b polymerase with IC50 = 45 nM, one of the most potent HCV NS5b polymerase inhibitors reported.
    DOI:
    10.1021/jm0342109
点击查看最新优质反应信息

文献信息

  • NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE
    申请人:Sundaresan Kumar
    公开号:US20090239810A1
    公开(公告)日:2009-09-24
    The present invention relates to piperidine derivatives that act as inhibitors of stearoyl-CoA desaturase. The invention also relates to methods of preparing the compounds, compositions containing the compounds, and to methods of treatment using the compounds.
    本发明涉及作为硬脂酰辅酶A脱饱和酶抑制剂的哌啶衍生物。该发明还涉及制备这些化合物的方法、含有这些化合物的组合物,以及使用这些化合物进行治疗的方法。
  • Azido-Containing aryl β-Diketo acid HIV-1 integrase inhibitors
    作者:Xuechun Zhang、Godwin C.G Pais、Evguenia S Svarovskaia、Christophe Marchand、Allison A Johnson、Rajeshri G Karki、Marc C Nicklaus、Vinay K Pathak、Yves Pommier、Terrence R Burke
    DOI:10.1016/s0960-894x(03)00059-3
    日期:2003.3
    Aryl beta-diketo acids (ADK) comprise a general class of potent HIV-1 integrase (IN) inhibitors, which can exhibit selective inhibition of strand transfer reactions in extracellular recombinant IN assays and provide potent antiviral effects in HIV-infected cells. Recent studies have shown that polycyclic aryl or aryl rings bearing aryl-containing substituents are components of potent members of this class. Reported herein is the first use of azido functionality as an aryl replacement in beta-diketo acid IN inhibitors. The ability of azido-containing inhibitors to exhibit potent inhibition of IN and antiviral protection in HIV-infected cells, renders the azide group of potential value in the further development of ADK-based IN inhibitors. (C) 2003 Elsevier Science Ltd. All rights reserved.
  • OKA Y.; ITOH K.; MIYAKE A.; TADA N.; OMURA K.; TOMIMOTO M.; YURUGI S., CHEM. AND PHARM. BULL.<CPBT-AL>, 1975, 23, NO 10, 2306-2317
    作者:OKA Y.、 ITOH K.、 MIYAKE A.、 TADA N.、 OMURA K.、 TOMIMOTO M.、 YURUGI S.
    DOI:——
    日期:——
  • NOVEL PIPERIDINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE
    申请人:Forest Laboratories Holdings Limited
    公开号:EP2268143A2
    公开(公告)日:2011-01-05
  • US8129376B2
    申请人:——
    公开号:US8129376B2
    公开(公告)日:2012-03-06
查看更多